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Ketamine’s Role in Spirituality:  




G. William Barnard1 
ABSTRACT 
This article highlights the potential spiritual effects of a popular anesthetic, ketamine, and how these spiritual effects can be used 
to help promote the reconciliation of spiritual and physical health. Ketamine, like the prominent psychedelic, psilocybin, has 
reportedly caused feelings of spiritual revelation and “out of body experiences” that many physicians may not feel qualified to 
discuss with their patients. This reluctance to address ketamine-induced spiritual experiences may affect the health outcomes of the 
patient. The primary goal of this project is to bring academic validity to considerations of the spiritual health of patients. This paper 
(1) investigates the extent that ketamine-induced, non-ordinary experiences can help bring awareness to the compatibility of 
spiritual and physical health and (2) compares the mechanisms of ketamine and psilocybin, as well as their value to the medical 
community due to the spiritual experiences that they catalyze. Thus, this research seeks to demonstrate that understanding the 




To better understand how ketamine-induced 
experiences are potentially “spiritual” in nature, we first 
have to clarify the term “spiritual.” For the purposes of this 
paper, spiritual can be defined as something that is more than 
our typical waking reality—it is, at its most expansive, the 
experience of becoming one with all that exists, going 
beyond the boundaries of time and space. These spiritual 
experiences present an interesting challenge to modern 
medicine. As American medicine has become increasingly 
scientific, the focus of physicians has centered on physical 
and psychological care. However, there was a time that 
American hospitals emphasized spiritual well-being as well. 
According to Dr. Puchalski, in 1910, American medicine 
changed course. The Flexner Report laid an important 
foundation for American medical education’s footing in the 
physical sciences. Unfortunately, this newfound grounding 
undermined the spiritual elements of patient care 
(Puchalski). Spirituality had a prominent role in establishing 
American healthcare for centuries but was quickly masked 
by the technological advances of the 20th century. With new 
treatments and diagnoses, numerous lives were saved but at 
the cost of once traditional medical values. American 
medicine soon adopted an empirical model and the once 
holistic field that accepted both secular and metaphysical 
ideologies was lost. Many Western physicians, specifically 
in the United States, had become intellectually advanced, but 
according to Puchalski, medical personnel across the country 
were becoming less and less equipped to pick up on the 
 
1 Dr. Barnard is a Professor of Religious Studies in SMU’s Department of Religious Studies. 
emotional (verbal and nonverbal) language of their patients. 
Puchalski goes on to suggest that a part of this emotional 
opacity was caused by the segregation of spirituality and 
medicine (Puchalski). Yet, at the start of the 21st century, 
researchers have begun to rediscover spirituality’s potential 
effect on physical and mental health (Puchalski).  
Modern medicine has made significant progress in 
identifying and acknowledging the importance of spirituality 
and what can invoke these experiences. While there is no 
way to quantitatively measure a spiritual response, the 
qualitative data attained from these studies are important 
nonetheless. Some researchers, however, have found 
significant similarities between anesthetics and psilocybin—
the active ingredient in several species of mushrooms that 
catalyzes psychedelic experiences—in the physical and 
subjective way the two affect the brain. Recent studies have 
begun to gather empirical data on the physical effects of 
psychedelics on the brain and have created theoretical 
frameworks for making sense of the spiritual experiences 
that are so often associated with the use of psychedelic 
substances. Namely, in the article “Altered States: 
Psychedelics and Anesthetics,” Eduardo E. Icaza reports, 
“By comparing psychedelic and anesthetic pathways that 
can alter or even ‘heighten’ consciousness, we may be able 
to identify key brain areas and networks that mediate 
conscious experience” (Icaza 1258). Neuroimaging 
techniques have shown that psilocybin decreases cerebral 
blood flow and have uncovered patterns of functional 
disconnections like many anesthetics. Psilocybin 
significantly decreases cerebral blood flow in the posterior 
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cingulate cortex, thalamus, and anterior cingulate cortex. 
Furthermore, psilocybin reduces functional connectivity 
between the anterior and posterior regions of the cortex, 
similar to brain patterns found during anesthesia (Icaza 
1257). For our purposes, psilocybin brain pathways compare 
to those of ketamine by similar decreased connectivity in the 
amygdala and anterior cingulate cortex. It is important to 
note that this similarity is based on low-dose administrations 
of ketamine (Icaza 1258). In anesthetic doses of ketamine, 
there are significant reductions of thalamus activity like what 
is found with psilocybin. The regulation of our waking 
conscious and the connectivity between our emotions, 
intelligence, concentration and self-awareness, as well as our 
spatial and visual perception are altered similarly by 
psilocybin and general anesthesia. 
This biological approach to examining these 
substances was supported by Michael van Elk in his article, 
“Brain Mechanisms in Religion and Spirituality: An 
Integrative Predictive Processing Framework”. In this 
article, van Elk reported a five-point biological model for the 
relationship between religious and spiritual experiences and 
the brain: 
 
1. Temporal brain areas 
Brain Structures: Hippocampus, Amygdala, 
Superior Temporal Sulcus; Medial Temporal 
Lobes; Fusiform Face Area 
 
Function: Memory retrieval; Emotional coloring 
of experience; Biological motion perception; 
Face perception 
 
Religious and Spiritual Beliefs: Visions; 
Hallucinations; Deja-vu experiences 
 
2. Multisensory Integration 
Brain Structures: Temporo-Parietal Junction; 
Superior Parietal Lobe; Inferior Parietal Lobe 
 
Function: Bodily self-consciousness; 
Multisensory integration 
 
Religious and Spiritual Beliefs: Mystical 
experiences; self-transcendence; out-of-body 
experiences; feeling of a presence 
 
3. Default Mode Network 
Brain Structures: Posterior Cingulate Cortex; 
Precuneus; Inferior Parietal Lobe; Lateral 
Temporal Cortex 
 
Function: Self-referential processing; Mind-
wandering 
 
Religious and Spiritual Beliefs: Mystical 
experiences; Ego dissolution; Reflective religious 
beliefs 
 
4. Theory-of-Mind Network 
Brain Structures: Medial Prefrontal Cortex; 
Superior Temporal Sulcus; Temporo-Parietal 
Junction 
 
Function: Social Cognition; Communication; 
Intentionality perception 
 
Religious and Spiritual Beliefs: Prayer; Belief in 
personal God; Over-attribution of agency 
 
5. Error-Monitoring Mechanisms 
Brain Structures: Anterior Cingulate Cortex; 
Medial Prefrontal Cortex; dopaminergic system 
 
Function: Prediction error-monitoring; Belief-
maintenance and updating 
 
Religious and Spiritual Beliefs: Openness to 
religious authority and rituals 
 
Both psilocybin and ketamine cause decreased 
amygdala connectivity. This promotes an emotional 
disconnection between what is felt during the typical, 
waking reality and what is felt under the influence of the 
psychedelic or anesthetic. Translating this to transcendental 
functions by van Elk’s biological model above, we see that 
the amygdala helps regulate religious and spiritual visions 
and hallucinations. In the absence of metaphysical 
influences, the amygdala is a part of the limbic system—
mediating emotion and memory. More specifically, the 
amygdala is associated with positive emotions and 
rewarding stimuli (Salzman). When considering both the 
psychedelic cognitive effects of psilocybin and the supposed 
spiritual nature of ketamine, healthy individuals may 
encounter positive or relatively safe visions or hallucinations 
that encourage sanguine feelings in order to (1) escape 
external stresses or (2) find more effective ways to deal with 
those external stress factors. Decreased amygdala 
connectivity induced by both drugs, then, is the result of the 
individual shifting their attention from the normal conscious 
world of experience and entering the subconscious in order 
to explore emotions in a different way than they would 
normally be able to do. This exploration of emotions, 
therefore, comes in the form of hallucinations and visions 
that cannot be seen if amygdala connectivity had not been 
altered. Most importantly, feelings produced from the 
amygdala during both psilocybin and ketamine trips are 
highly likely to affect the individual after their psychedelic 
explorations. Regarding patient care, this can translate to 
better recovery outcomes due to the positive affirmations 
and/or the emotional security that was established by the 
visions during the trip. 
The anterior cingulate cortex is a “meeting place” 
for the limbic system, that mediates emotion, and the 
prefrontal cortex, that mediates cognition. The anterior 
cingulate cortex, therefore, is likely to regulate an 
individual’s ability to control and manage uncomfortable 
emotions (Stevens). In van Elk’s biological model for 
spiritual experiences, the anterior cingulate cortex helps 
regulate error-monitoring mechanisms and belief 
maintenance. In terms of spiritual beliefs, the anterior 
cingulate cortex promotes openness to religious authority 
and rituals. As Icaza reported, both ketamine and psilocybin 
influence the brain by decreasing anterior cingulate 
connectivity. A healthy individual’s ability to control, avoid, 
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and regulate painful emotions are mediated by the ACC. If 
these connections are altered—and more specifically 
decreased by the activity of psilocybin and ketamine—this 
allows more abstract approaches to dealing with such 
emotions to be utilized. Therefore, under spiritual influences 
such as those that are at times provided by ketamine, 
authoritative religious figures or beliefs can be a determining 
factor in how the individual reacts to stresses after their 
psychedelic experience.  
These similarities in the biological mechanisms of 
the two drugs are supported in the post-psychedelic 
recollections of several healthy individuals. Although van 
Elk established a biological model for making sense of 
general spiritual experiences, Dr. Eli Kolp provided a 
different approach to studying the effects of spiritual 
experiences on the brain. Dr. Kolp, with the assistance of 
other physicians and researchers, studied the conscious 
effects of ketamine in a psychedelic psychotherapy study, 
focusing on the phenomenology and clinical applications of 
the profound mystical effects of the drug. Psychedelic 
psychotherapy typically occurs while the patient is under the 
influence of a psychedelic. From this study, Dr. Kolp 
reported that when using: 
“…one-sixth to one-tenth of the dose used for 
general anesthesia, ketamine can create psychedelic 
experiences with disconnection from surroundings, 
perception of floating becoming disembodied as a mind or 
soul, and even dying and going to a different world…loss of 
reality contact appears more pronounced than with other 
psychedelics” (Kolp, et al). 
These sub-anesthetic does of ketamine can 
produce the shifts in conscious thought that encourage 
spiritual experiences. Dr. Andrew Bowdle, author of 
“Psychedelic Effects of Ketamine in Healthy Volunteers: 
Relationship to Steady-state Plasma Concentrations,” stated 
“ketamine produced dose-related psychedelic effects”—
supporting that different doses of ketamine can produce 
significantly psychedelic, and thus, spiritual experiences 
(82). Dr. Bowdle also reported, “Awareness of these effects 
may help clinicians using subanesthetic doses of ketamine 
improve their management of patients, particularly with 
regard to effective communication with patients” (86). 
Specifically, the effects that Dr. Bowdle refers to are 
explicitly stated in Dr. Kolp’s article, “Ketamine 
Psychedelic Psychotherapy: Focus on Its Pharmacology, 
Phenomenology, and Clinical Applications.” According to 
Dr. Kolp, the ketamine-induced, non-ordinary experiences 
may include: 
Emotionally intense visions (deceased relatives, 
angels, spirits) 
 
Encounters with archetypal beings (Christ, 
Buddha, Krishna) 
 
Feelings of cosmic unity with the Universe and 
God 
 
Sense of sacredness 
 
Feelings of interconnectedness with all people and 
nature 
 
The above components of ketamine-induced 
experiences directly align with ketamine’s involvement in 
altering the amygdala (emotionally intense visions, 
encounters with archetypal beings) and the anterior cingulate 
cortex (feelings of cosmic unity with the Universe and God) 
as reported by Dr. Icaza.  
At high doses, ketamine experiences can induce an 
ego-dissolving, transcendental experience for the patient, 
including: 
Feelings of interconnectedness with all people (or 
sense of experiencing collective consciousness) 
 
Feelings of becoming God, frequently experiences 
as an ocean of brilliant white light 
 
Profound sense of sacredness of the experience 
 
These ego-dissolving, transcendental experiences 
can generate some resolution of the patient’s addictive 
illnesses, psychological problems, and personality disorders, 
including spontaneous healing from chronic psychosomatic 
illnesses (Kolp, et al). It is important to note that 
transcendental experiences can occur with subanesthetic and 
high doses of ketamine.  
2. METHODOLOGY 
This project is constructed as a literature review. 
Specifically, it analyzes previous studies on the spiritual 
aspect of ketamine and how these ketamine experiences can 
help establish a more holistic healthcare system. This 
project also compares the spiritual experiences between 
ketamine and psilocybin, a classic psychedelic that has also 
been reported to provide "spiritual" effects. The mystical 
experiences induced by psilocybin have been found to have 
enormous value, specifically in psychotherapy. This 
comparison will be used to question whether ketamine-
induced experiences should be deemed valuable as well. 
Finally, the comparison of ketamine to psilocybin as well 
as testimonies of ketamine users will be used to argue the 
necessity of reconciling spiritual and physical health.  
Most sources were collected from the PubMed 
National Library of Medicine database. Search terms 
included “spirituality and medicine,” “spirituality and 
health,” “spirituality and ketamine,” “ketamine and 
psychedelics,” and “psychedelics and medicine.”  The peer-
reviewed journal of the American Society of 
Anesthesiologists was employed as well. Search terms from 
this journal included “anesthetics and spirituality,” 
“anesthetics and mystical experiences,” and “anesthetics 
and psychedelics.” 
 
 3. RESULTS 
The spiritual testimonies of recreational ketamine 
users were compelling. One user reported: 
“I rose into the Light and found myself having an 
unspoken interchange with the Light, which I believed to be 
God, about matters which seemed to be of central 
importance to my Life and who I was. I didn’t believe in 
God, which made the [ketamine] experience even more 
startling. That experience seriously shook the basis of my 
belief” (Jansen 99). 
Another user revealed, 
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“[Ketamine] was very upsetting, and it did shake 
my atheism, very much so. I’m just really pleased that I 
found it when I did because I think it was a Godsend actually. 
I regard [ketamine] as a sort of spiritual enhancer” (Jansen 
101-105). 
Those who have had experience with ketamine 
insist that the events they encounter are real—they are not 
hallucinations or dreams.  These first-hand accounts do 
support the hypothesis that ketamine experiences are 
spiritually valuable. To offer a description of how influential 
ketamine-induced experiences are to patient care, and thus, 
the reconciliation of spiritual and physical health, I employ 
a room-door metaphor illustrating the importance of 
recognizing this transcendental phenomenon to the physical 
body: 
If we consider the physical body to be a door 
leading to a room, the room will symbolize the 
subconscious. Within this room holds our ability, or 
capacity, to have, maintain, and regulate transcendental 
experiences. When we think of a room, we presume the door 
is a part of the room. The two are not dissociated, or separate 
from one another, but are instead, considered to be 
distinguishable. An individual is only ever to acknowledge 
the subconscious when he or she separates themselves from 
the conscious, waking reality. Ketamine is an avenue to 
promote this separation.  
The physical mechanisms that are affected by 
ketamine in anesthetic practices directly affect the state of 
the conscious mind by increasing subconscious activity. 
With heightened subconscious awareness, the capacity to 
welcome and understand spiritual concepts is increased, and 
the result of doing so can affect how the patient chooses to 
physically manage their recovery process.  
There are other side effects of ketamine. “K pains” 
are severe stomach pains that can hospitalize the user. Karl 
Jansen reported in his book, Ketamine: Dreams and 
Realities, that these “K pains” are a form of irritable bowel 
syndrome (Jansen 271). These stomach pains may be the 
physiological result of emotional stress that occurs when the 
user is undergoing a powerful ketamine-induced psychedelic 
experience. Other physiological responses due to ketamine-
induced, non-ordinary experiences can include chest pain 
and rapid heartbeat, increased blood pressure, and increased 
susceptibility to infection (Schneiderman).  Physicians, 
specifically anesthesiologists, should consider these 
experiences important to their patients’ health in that 
neurotic experiences often have physiological effects.  
However, as Dr. Bowdle notes, “anesthesiologists tend to 
associate the psychedelic effects of ketamine with 
emergence from anesthesia, after use of ketamine as an 
induction agent, which is often referred to as ‘emergence 
reactions’” (Bowdle, et al). Roughly 55% of those 
administered ketamine will experience an emergence 
reaction that mimics schizophrenia and increases that 
patient’s risk of injury (Aroke, et al). The misattribution of 
these spiritual experiences as emergence phenomena 
accredited to mental illness, and the physician’s 
subconscious treatment of post-ketamine reactions as such, 
can arguably create unintended roadblocks in the patient’s 
treatment.  
Although harmful side effects can occur, 
ketamine-induced, non-ordinary experiences can encourage 
stable recovery from illness and injury by promoting 
patients’ psychospiritual growth (Ketamine-Enhanced 
Psychotherapy). Spirituality can be utilized as a method to 
relieve physical symptoms and to confront and endure the 
emotional distress that can accompany physical illness. 
Patient recovery is largely dependent upon the individual’s 
ability to relate to their self, to others, and to the physical 
world. For example, transcendental experiences can stabilize 
emotional responses to external stressors, such as physical 
injury. Without healthy emotional responses, the body 
cannot respond properly because that unhealthy emotional 
response has become an acute, or in severe cases, chronic, 
stressor. For the purposes of this paper, these unhealthy 
emotional responses can occur because of distressing or off-
putting visions or hallucinations while undergoing a 
ketamine trip. These can induce a vascular response, 
specifically, increasing blood pressure through constriction 
(Schneiderman). Minimizing the effect spirituality has on 
physical recovery can risk the progress of a patient’s return 
to health.  
Dr. Matthew Johnson conducted a study analyzing 
psilocybin and its mystical effects during several therapeutic 
trials related to the psychological distress and depression 
catalyzed by cancer. His analysis suggested that the positive 
therapeutic outcomes are mediated by the drug’s ability to 
produce spiritual experiences (Johnson 95). These non-
ordinary, mystical experiences produced from psilocybin 
include changes in perceptual, cognitive, and affective 
thinking (Griffiths). Psilocybin is a part of a serotonin-
mediated class of hallucinogens, along with lysergic acid 
diethylamide (LSD) and N,N-dimethyltryptamine (DMT). 
Prominent themes of serotonergic-hallucinogenic 





Contact and unification with an authoritative 
presence 
 
Experience of a white light 
 
Certainty that consciousness continues after 
physical death 
 
Firsthand knowledge of the ‘facts’ of creation, 
existence, and consciousness 
 
Prominent themes of ketamine-induced, non-
ordinary experiences include (Kolp, et al): 
Feelings of becoming God 
 
Sense of sacredness 
 
Feelings of cosmic unity with the Universe and 
God 
 
Encounters with archetypal beings 
 
Emotionally intense visions 
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Similarities between the synthetic drug, ketamine, 
and the plant-produced psilocybin include euphoria, 
peacefulness, spiritual awakening, and quickly changing 
emotions. More apparent similarities are depersonalization, 
and distorted thinking and/or rationales. These similarities 
are characterized by their abruptness and by their ability to 
be sustained over significant periods of time. This research 
also indicates that ketamine-induced experiences do not 
produce lasting effects as consistently as psilocybin-induced 
experiences. In a dose-dependent psilocybin study analyzing 
the long-term psychological effects of hallucinogenics, 
researchers found that high-dose psilocybin (20-30 
mg/70Kg) produced acute and persisting effects after six 
months. Participants in the study experienced lasting 
feelings of interpersonal closeness, death transcendence, 
daily spiritual experiences, and religious faith and coping 
(Griffiths, et al). Typical therapeutic psilocybin dosage is 25 
– 30 mg/70kg. The similarity in therapeutic and non-
therapeutic psilocybin dosage, and lack thereof for ketamine,  
can explain why ketamine-induced experiences have not 
been understood to be as psychologically valuable as the 
experiences catalyzed by psilocybin. The lack of research 
regarding dose-related ketamine-induced experiences in 
various sets and settings, in addition to positive therapeutic 
results attributed to psilocybin due to its capacity to produce 
these mystical experiences, helps establish psilocybin’s 
effectiveness but does not signify ketamine’s relevance in a 
bio-spiritual context. With more research, it may be possible 
for ketamine-induced experiences to also be medically 
valuable. 
Regarding the need for spiritual concern in 
medicine, Dr. John Tarpley examined public opinion polls 
and surveys that showed that the majority of patients want 
their physicians to inquire about their spiritual concerns and 
health. However, studies also indicated that many physicians 
were uncomfortable discussing spiritual issues (Tarpley 
644). Additionally, Doctor Elaine Yuen proposed that 
spiritual and religious practices have benefited those with 
physical conditions such as kidney disease, cancer, 
cardiovascular disease, HIV, and diabetes mellitus. Religion 
and spirituality also support psychological coping 
mechanisms, addressing the physical discomfort that 
accompanies illness and injury (77). Effective 
communication practices regarding patients’ spiritual health 
and experiences do require physicians to be more present as 
a person, rather than as a physician. It is important to the 
patient’s health and to the overall patient-physician 
relationship for the physician to be more attentive to all 
possible causes of patient suffering, and in some ways, to 
separate themselves from their profession in order to gain 
better insight about the patient. This willingness of a 
physician to be a fellow human welcomes patient 
vulnerability and allows the physician to familiarize 
themselves with the patient’s personal experiences, which, if 
need be, can be appropriately incorporated into their 
treatment plan. 
4. DISCUSSION 
This paper aims to provide a context to examine 
the extent that ketamine-induced, non-ordinary experiences 
can help bring awareness of the compatibility of spiritual and 
physical health. To study this principal question, 
comparisons were made between the anesthetic ketamine 
and a serotonergic hallucinogen, psilocybin. In addition, the 
validity of these ketamine-induced spiritual experiences was 
examined. To fully understand the capacity that ketamine 
possesses to help reconcile spiritual and physical health, it is 
crucial that spiritual health, as distinct from spirituality, be 
better defined in any future research. 
Physical, mental, and social perspectives all make 
up the human experience. However, the aspects of human 
existence that cannot be rationalized within these contexts 
make up individual spiritual health. Spiritual health is an 
actualization of the differing capacities of human existence. 
It is how well the individual functions in a shared, waking 
reality with others based on their individual knowledge of 
what they perceive to exceed this shared reality. Spiritual 
health, at its essence then, is the balance between the 
physical and emotional aspects of existence. It is how we 
tangibly and cognitively perceive ourselves in relation to 
other existing possibilities as we know them. Spiritual health 
does not require constant internalization of positive feelings 
or belief in a higher power. Instead, it requires individual 
discernment of all possible forms of existence. The idea of 
being spiritually unhealthy, therefore, is the result of 
dissonance between the individual’s understanding of 
transcendent ideas and their everyday, waking reality.  
Ketamine can be utilized to promote the 
reconciliation of spiritual and physical health by (1) 
encouraging the patient to challenge traditional social 
constructs and belief patterns at the cost of discovering 
personal revelations; (2) inducing psychological stressors 
that can have physical effects; and (3) allowing for more 
open patient-physician conversations. As Kolp described, 
“…the ego-dissolving transcendental experiences [of 
ketamine] sometimes generate some resolution of the 
patient’s addictive illnesses, psychological problems, and 
personality disorders, including of spontaneous healing from 
chronic psychosomatic illnesses” (Kolp, et al). It is clear that 
discussing personal experiences such as these can at times 
create discomfort for the physician and/or patient; however, 
the vulnerability experienced during these conversations 
could have substantial positive outcomes on the patient’s 
ability to manage physical injury.  These types of 
conversations would require an intimate relationship 
between the patient and physician in order to discuss the 
aftermath of ketamine-induced, non-ordinary experiences, 
and the willingness of the physician to consider those 
experiences in their treatment plans.  
Ketamine is of special interest in integrating 
spirituality and modern medicine because of its role in pain 
management. Pain perception is composed not only of 
physical mechanisms and response, but emotional factors as 
well. Spiritual stressors can catalyze pain responses, and 
ketamine-induced, non-ordinary experiences at anesthetic 
doses can alter patients’ pain perception. Subsequently, pain 
management options should reflect these non-physiological 
factors. To efficiently assign pain treatment options, 
however, physicians must possess a comprehensive 
understanding of these ketamine-induced experiences.  
Patients’ capacity to tolerate and accept disease 
and injury requires multiple levels of experience and thought 
(Dedeli). The psychedelic effects associated with ketamine 
encourages a detachment from these thoughts processes—
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bringing forth a sense of intense and often overwhelming 
spiritual vulnerability for the patient. Therefore, an 
individual’s perception of pain may be significantly altered 
by ketamine because he or she is not experiencing typical, 
waking-reality thought processes but is instead experiencing 
unfamiliar, subconscious levels of thought. That is to say, 
these spiritual experiences are ordinarily invisible to us and 
are inaccessible using our normal states of consciousness 
(Strassman 54). Consequently, these spiritual-in-nature, 
ketamine variables may alter the patients’ response to 
various pain experiences, thus affecting their recovery 
options (Dedeli). 
5. CONCLUSION 
This paper does not encourage the recreational use 
of ketamine, nor does it propose ketamine should be utilized 
as a therapeutic substance. However, this paper aims to raise 
questions regarding training improvements for medical 
students. It is important to objectively measure the level of 
“spiritual training” necessary to become knowledgeable 
with spiritual health, and therefore how to improve the 
patient-physician relationship. Going further, future studies 
would need to objectively measure the direct relationship 
specifically between ketamine-induced experiences and the 
physical outcomes of treatment to provide a more stable 
argument for the compatibility of spiritual and physical 
health. 
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